期刊文献+

葡萄糖转运体9(GLUT9)基因启动子区的rs13124007(G/C)及rs6850166(G/A)位点的单核苷酸多态性(SNP)与汉族女性痛风相关性研究(英文) 被引量:3

Association of the Polymorphisms of rs13124007(G/C), rs6850166(G/A) in the Promoter of GLUT9 with Gout in Chinese Han Female
原文传递
导出
摘要 目的:探讨葡萄糖转运体9(GLUT9)基因启动子区的rs13124007(C/G)及rs6850166(A/G)位点的单核苷酸多态性(SNP)与中国汉族女性人群痛风易感性之间的相关性。方法:选取185例痛风患者和300例正常对照者,提取基因组DNA,采用聚合酶链式反应(PCR技术),特异性扩增GLUT9基因所需要的目的片段,对扩增的目的片段进行测序后,比较痛风组和正常对照组的基因型频率及等位基因频率分布情况。结果:女性痛风组中GLUT9基因的启动子区rs13124007和rs6805116两个位点的基因型频率分布与正常对照组相比,统计学上无明显的差异(X2=0.906,P=0.636;X2=3.335,P=0.189),rs13124007 SNP位点的C等位基因频率和rs6850166SNP位点的A的等位基因频率与正常对照组相比也无明显的统计学差异(X2=0.506,P=0.477;X2=3.268,P=0.071)。结论:葡萄糖转运体9(GLUT9)基因启动子区的rs13124007(C/G)及rs6850166(A/G)位点的单核苷酸多态性(SNP)与中国汉族女性人群痛风易感性无明显的相关性。 Objective: To investigate the relationship between gout and polymorphisms of rs13124007 and rs6850166 in the promoter of GLUT9 in Chinese Han females.Methods: 184 gout patients and 306 healthy controls were entrolled.Specifically amplify the target fragments of GLUT9 gene was performed by polymerase chain reaction(PCR) technology.PCR product was sequenced directly.The genotype frequencies and allelic frequencies of the two groups were compared.Results: There was no statistical difference for rs13124007(G/C) and rs6850166(G/A) genotype frequencies between the gout patients and controls(X 2 =0.906,P=0.636;X 2 =3.335,P=0.189).The C allele of rs13124007 did not appear as the risk allele for susceptibility to gout(X 2 =0.506,P=0.477,OR=1.16,[95% CI 0.77-1.76]),and the A allele of rs6850166 in the gout group were not significantly higher than that in the controls(X 2 =3.268,P=0.071,OR=1.50,[95% CI 0.96-2.34]).Conclusion: The polymorphisms of rs13124007(G/C),rs6850166(G/A) in the promoter of GLUT9 are not obviously associated with susceptibility to gout in Chinese Han females.
出处 《现代生物医学进展》 CAS 2013年第13期2493-2497,共5页 Progress in Modern Biomedicine
基金 Natural Science Foundation of China(81070686)~~
关键词 GLUT9 痛风 单核苷酸多态性 汉族女性人群 GLUT9 Gout Single nucleotide polymorphism Chinese Han female
  • 相关文献

参考文献23

  • 1Ea HK, Bardin T, Jinnah HA, et al. Severe gouty arthritis and mild neurologic symptoms due to F199C, a newly identified variant of the hypoxanthine guanine phosphoribosyl transferase [J]. Arthritis Rheum,2009,60(7):2201-2204.
  • 2Yang Q, Dehqhan A, Smith AV, et al. Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors[J]. Circ Cardiovasc Genet,2008,3(6):523-530.
  • 3Caulfield M J, Munroe P B, O'Neill D, et al. SLC2A9 is a high-capacity urate transporter in humans [J]. PLoS Med,2008,5(10): e197-201.
  • 4Hart TC, Gorry MC, Hart PS, et al. Mutations of the UMOD gene are responsible for medullary cystic kidney disease 2 and familial juvenile hyperuricaemic nephropathy [J]. J Med Genet,2002,39(12): 882-892.
  • 5Yamada Y, Nomura N, Yamada K, et al. Molecular analysis of hypoxanthine guanine phosphoribosyltransferase (HPRT) deficien?cies: novel mutations and the spectrum of Japanese mutations [J]. Nucleosides Nucleotides Nucleic Acids,2008,27(6):570-574.
  • 6Yamada Y, Yamada K, Nomura N, et al. Molecular analysis of two enzyme genes, HPRTl and PRPSI, causing X-linked inborn errors of purine metabolism [J]. Nucleosides Nucleotides Nucleic Acids, 2004,29(6):291-294.
  • 7Vitart V, Rudan I, Hayward C, et al. SLC2A9 is a newly identified orate transporter influencing serum wale concentration, orate excretion and gout[J]. Nat Genet,2008,40(4):437-442.
  • 8Doring A, Gieger C, Mehta D, et al. SLC2A9 influences uric acid concentrations with pronounces sex-specific effects [J]. Nat Genet, 2008,40(4):430-436.
  • 9McArdle PF, Parsa A, Chang YP, et al. Association of a common nonsynonymous variant in GLUT9 with serum uric acid levels in old order amish[J]. Arthritis Rheum,2008,58(9):2874-2881.
  • 10Li S, Sauna S, Maschio A, et al. The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts[J]. PLoS Genet ,2007,3(11):e194-198.

同被引文献37

  • 1Choi HK, Ford ES, Li C, et al. Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey.Arthritis Rheum, 2007,57 ( 1 ) : 109-115.
  • 2Abbott RD, Brand FN, Kannel WB, et al. Gout and coronary heart disease : the Framingham Study. J Clin Epidemiol, 1988, 41 ( 3 ) : 237-242.
  • 3Sakurai H. Urate transporters in the genomic era. Curt Opin Nephrol Hypertens, 2013,22 ( 5 ) : 545-550.
  • 4Reginato AM, Mount DB, Yang I, et al.The geneties of hyperurieaemia and gout.Nat Rev Rheumatol,2012,8(10) :610-621.
  • 5Kolz M, Johnson T, Sanna S, et al. Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations.PLoS Genet, 2009,5 (6) : e 1000504.
  • 6Yang Q, Kottgen A, Dehghan A, et al. Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovasculardisease risk factors. Cite Cardiovasc Genet, 2010,3 (6) : 523-530.
  • 7Ktittgen A, Albrecht E, Teumer A, et al. Genome-wide association analyses identify 18 new loci associated with serum urate concentrations.Nat Genet, 2013,45(2) : 145-154.
  • 8Dinour D, Gray NK, Ganon L, et al. Two novel homozygous SLC2A9 mutations cause renal hypouricemia type 2. Nephrol Dial Transplant, 2012,27(3) : 1035-1041.
  • 9Charles BA, Shriner D, Doumatey A, et al. A genome-wide association study of serum uric acid in African Americans.BMC Med Genomics, 2011,4:17.
  • 10Karns R, Zhang G, Sun G, et al. Genome-wide association of serum uric acid concentration:replication of sequence variants in an island population of the Adriatic coast of Croatia.Ann Hum Genet, 2012,76 (2) : 121-127.

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部